IndraLab

Statements

USP37 activates Hypoxia. 1 / 1

| 1

reach

"USP37 contributes to cancer progression by deubiquitinating and stabilizing hypoxia-inducible factor 2α (HIF2α), a key driver of tumor adaptation to hypoxic conditions, thereby promoting tumor growth, angiogenesis, and metastasis [23]."

40188027

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP37 activates Hypoxia. 1 / 1

INDRA sources:

Databases

Reading